Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001624526-16-000004
Filing Date
2016-12-20
Accepted
2016-12-20 13:42:38
Documents
1
Effectiveness Date
2016-12-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8062
  Complete submission text file 0001624526-16-000004.txt   9110
Mailing Address 263 SUMMER STREET 4TH FLOOR BOSTON MA 02210
Business Address 263 SUMMER STREET 4TH FLOOR BOSTON MA 02210 650-463-4052
Cure Forward Corp. (Filer) CIK: 0001624526 (see all company filings)

EIN.: 461272619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-276663 | Film No.: 162061009